Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems

Shuanglin Hao, Osamu Takahata, Keiko Mamiya, Hiroshi Iwasaki

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

We investigated the antagonism of sevoflurane antinociception by opioid antagonists in the rat formalin test. Formalin injection into the hindpaw of the rat induces the nocifensive flinching behavior and the expression of Fos-like immunoreactivity (Fos-LI) in the spinal cord. Sevoflurane significantly suppressed the flinching behavior and decreased the number of Fos-LI neurons in the dorsal horn of spinal cord compared with the control group. Moreover, pretreatment with intraperitoneal naloxone plus naltrexone antagonized the suppression of flinching behavior and the decrease of the number of Fos-LI neurons produced by 3% sevoflurane. Intraperitoneal opioid antagonists themselves had no effects on both the behavior response and the expression of Fos-LI induced by formalin injection. This study supports the hypothesis that sevoflurane suppresses the nociceptive response, at least in part, by activating endogenous opioid systems.

Original languageEnglish
Pages (from-to)571-580
Number of pages10
JournalLife Sciences
Volume71
Issue number5
DOIs
StatePublished - Jun 21 2002
Externally publishedYes

Fingerprint

Opioid Analgesics
Rats
Spinal Cord
Chemical activation
Formaldehyde
Narcotic Antagonists
Neurons
Posterior Horn Cells
Naltrexone
Injections
Pain Measurement
Naloxone
Control Groups
sevoflurane

Keywords

  • Endogenous opioid systems
  • Formalin test
  • Fos-like immunoreactivity
  • Sevoflurane

ASJC Scopus subject areas

  • Pharmacology

Cite this

Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems. / Hao, Shuanglin; Takahata, Osamu; Mamiya, Keiko; Iwasaki, Hiroshi.

In: Life Sciences, Vol. 71, No. 5, 21.06.2002, p. 571-580.

Research output: Contribution to journalArticle

@article{7ad7ffb7c4ea460e9abd867b1e5556da,
title = "Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems",
abstract = "We investigated the antagonism of sevoflurane antinociception by opioid antagonists in the rat formalin test. Formalin injection into the hindpaw of the rat induces the nocifensive flinching behavior and the expression of Fos-like immunoreactivity (Fos-LI) in the spinal cord. Sevoflurane significantly suppressed the flinching behavior and decreased the number of Fos-LI neurons in the dorsal horn of spinal cord compared with the control group. Moreover, pretreatment with intraperitoneal naloxone plus naltrexone antagonized the suppression of flinching behavior and the decrease of the number of Fos-LI neurons produced by 3{\%} sevoflurane. Intraperitoneal opioid antagonists themselves had no effects on both the behavior response and the expression of Fos-LI induced by formalin injection. This study supports the hypothesis that sevoflurane suppresses the nociceptive response, at least in part, by activating endogenous opioid systems.",
keywords = "Endogenous opioid systems, Formalin test, Fos-like immunoreactivity, Sevoflurane",
author = "Shuanglin Hao and Osamu Takahata and Keiko Mamiya and Hiroshi Iwasaki",
year = "2002",
month = "6",
day = "21",
doi = "10.1016/S0024-3205(02)01704-6",
language = "English",
volume = "71",
pages = "571--580",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems

AU - Hao, Shuanglin

AU - Takahata, Osamu

AU - Mamiya, Keiko

AU - Iwasaki, Hiroshi

PY - 2002/6/21

Y1 - 2002/6/21

N2 - We investigated the antagonism of sevoflurane antinociception by opioid antagonists in the rat formalin test. Formalin injection into the hindpaw of the rat induces the nocifensive flinching behavior and the expression of Fos-like immunoreactivity (Fos-LI) in the spinal cord. Sevoflurane significantly suppressed the flinching behavior and decreased the number of Fos-LI neurons in the dorsal horn of spinal cord compared with the control group. Moreover, pretreatment with intraperitoneal naloxone plus naltrexone antagonized the suppression of flinching behavior and the decrease of the number of Fos-LI neurons produced by 3% sevoflurane. Intraperitoneal opioid antagonists themselves had no effects on both the behavior response and the expression of Fos-LI induced by formalin injection. This study supports the hypothesis that sevoflurane suppresses the nociceptive response, at least in part, by activating endogenous opioid systems.

AB - We investigated the antagonism of sevoflurane antinociception by opioid antagonists in the rat formalin test. Formalin injection into the hindpaw of the rat induces the nocifensive flinching behavior and the expression of Fos-like immunoreactivity (Fos-LI) in the spinal cord. Sevoflurane significantly suppressed the flinching behavior and decreased the number of Fos-LI neurons in the dorsal horn of spinal cord compared with the control group. Moreover, pretreatment with intraperitoneal naloxone plus naltrexone antagonized the suppression of flinching behavior and the decrease of the number of Fos-LI neurons produced by 3% sevoflurane. Intraperitoneal opioid antagonists themselves had no effects on both the behavior response and the expression of Fos-LI induced by formalin injection. This study supports the hypothesis that sevoflurane suppresses the nociceptive response, at least in part, by activating endogenous opioid systems.

KW - Endogenous opioid systems

KW - Formalin test

KW - Fos-like immunoreactivity

KW - Sevoflurane

UR - http://www.scopus.com/inward/record.url?scp=0037150747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037150747&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(02)01704-6

DO - 10.1016/S0024-3205(02)01704-6

M3 - Article

C2 - 12052441

AN - SCOPUS:0037150747

VL - 71

SP - 571

EP - 580

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 5

ER -